CATALYST DOSSIER · UPDATED 2026-11-09
$PACS
biotech · convergence -3 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $PACS?
Quantitative
Revenue (CY2026Q2) : $1.43B (+9.1% YoY)
Net Income (CY2026Q2) : $76.4M (+49.9% YoY)
Net Margin (CY2026Q3) : 4.1%
Catalysts
Multi-spoke convergence : 8 convergent signals fired: finra_short, auto_macro_adp_payrolls, auto_macro_banrep_colombia, auto_macro_bls_employment, auto_macro_durable_goods
Risks
Insider planned sale (Form 144) : <b>Filed:</b> 2026-11-06 <b>AccNo:</b> 0001968582-26-001124 <b>Size:</b> 5 KB 2026-11-06
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Sympathy basket (cerebro)
QBTS via tech r=+0.98 sympathetic (score 25)
WORX via tech r=+0.98 sympathetic (score 20)
NVDA via semis r=+0.88 sympathetic (score 21)
INDI via semis r=+0.88 sympathetic (score 17)
SKYD via comms r=+0.70 sympathetic (score 25)
TU via comms r=+0.70 sympathetic (score 20)
Signals Firing
finra_short auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-09-21 sec_clean_gappers +0.9% -1.3% — 2026-09-21 sec_top_gappers +0.9% -1.3% — 2026-09-21 sec_top_moat_emerging +0.9% -1.3% —
Lifetime: 0/3 wins · hit-rate 0.0% on +2% intraday
Sympathy Basket QBTS via tech · score 25 WORX via tech · score 20 NVDA via semis · score 21 INDI via semis · score 17 SKYD via comms · score 25 TU via comms · score 20
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.